BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-22

  1. 1,990 Posts.
    lightbulb Created with Sketch. 758
    IMO - This is reassuring compared to Matt selling. UBS can be selling for a stack of reasons most of which are innocent.

    I'd only be concerned if someone internal sold a large portion without an explanation.

    I too wish I had more $$ to be buying more.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.